Suchergebnisse - "EC 3.4.17.-"

PubPharm (13.268)

21

Involvement of Mast Cells in the Pathology of COVID-19 : Clinical and Laboratory Parallels

enthalten in: Cells | 2024

von Budnevsky, A. | Avdeev, S. | Kosanovic, D. | +8

22

The Recognition Pathway of the SARS-CoV-2 Spike Receptor-Binding Domain to Human Angiotensin-Converting Enzyme 2

enthalten in: Molecules (Basel, Switzerland) | 2024

von Peng, C. | Lv, X. | Zhang, Z. | +2

23

Adaptive immune responses to two-dose COVID-19 vaccine series in healthy Canadian adults ≥ 50 years : a prospective, observational cohort study

enthalten in: Scientific reports | 2024

von Gaultier, G. | McMillan, B. | Poloni, C. | +18

24

Enhancement of NETosis by ACE2-cross-reactive anti-SARS-CoV-2 RBD antibodies in patients with COVID-19

enthalten in: Journal of biomedical science | 2024

von Hsieh, K. | Chao, C. | Cheng, Y. | +9

25

Bioavailability and Metabolism of Bioactive Peptide IRW with Angiotensin-Converting Enzyme 2 (ACE2) Upregulatory Activity in Spontaneously Hypertensive Rats

enthalten in: Journal of agricultural and food chemistry | 2024

von Wang, Z. | Wang, C. | Fan, H. | +5

26

ACE2 acts as a novel regulator of TMPRSS2-catalyzed proteolytic activation of influenza A virus in airway cells

enthalten in: Journal of virology | 2024

von Heindl, M. | Rupp, A. | Schwerdtner, M. | +9

27

MiR-145-5p reduced ANG II-induced ACE2 shedding and the inflammatory response in alveolar epithelial cells by targeting ADAM17 and inhibiting the AT1R/ADAM17 pathway

enthalten in: European journal of pharmacology | 2024

von Wang, X. | Ma, J. | Lin, D. | +4

28

Thrombin activatable fibrinolysis inhibitor plasma levels and TAFI Thr325Ile genetic polymorphism in a cohort of Egyptian sickle cell disease patients and impact on disease severity

enthalten in: Pediatric blood & cancer | 2024

von Hamdy, M. | Shaheen, I. | Khallaf, M. | +1

29

A PSMA-targeted doxorubicin small-molecule drug conjugate

enthalten in: Bioorganic & medicinal chemistry letters | 2024

von Yoon, H. | Savoy, E. | Mesbahi, N. | +5

30

Natural Killer Cells Do Not Attenuate a Mouse-Adapted SARS-CoV-2-Induced Disease in Rag2-/- Mice

enthalten in: Viruses | 2024

von Ellsworth, C. | Wang, C. | Katz, A. | +9